Aceto Corporation  

(Public, NASDAQ:ACET)   Watch this stock  
Find more results for ACET
19.65
-0.45 (-2.24%)
After Hours: 20.00 +0.35 (1.78%)
Jan 19, 4:20PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 19.49 - 20.10
52 week 15.69 - 25.98
Open 20.00
Vol / Avg. 402,270.00/312,311.00
Mkt cap 582.40M
P/E 19.53
Div/yield 0.06/1.32
EPS 1.01
Shares 30.05M
Beta 1.51
Inst. own 83%
Feb 2, 2017
Q2 2017 Aceto Corp Earnings Release Add to calendar
Jan 12, 2017
Aceto Corp at JPMorgan Healthcare Conference
Jan 11, 2017
Aceto Corp at CJS Securities "New Ideas for the New Year" Investor Conference
Dec 1, 2016
Aceto Corp Annual Shareholders Meeting
Nov 3, 2016
Q1 2017 Aceto Corp Earnings Call
Nov 2, 2016
Q1 2017 Aceto Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin 3.43% 6.22%
Operating margin 6.85% 10.39%
EBITD margin - 12.81%
Return on average assets 3.24% 6.75%
Return on average equity 5.73% 12.45%
Employees 270 -
CDP Score - -

Address

4 Tri Harbor Ct
PORT WASHINGTON, NY 11050-4661
United States - Map
+1-516-6276000 (Phone)
+1-516-6276093 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.

Officers and directors

Albert L. Eilender Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Salvatore J Guccione Sr President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Douglas A Roth Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Vimal Kavuru Director, President of Rising
Age: 48
Bio & Compensation  - Reuters
Walter J. Kaczmarek III Chief Operating Officer
Age: 57
Bio & Compensation  - Reuters
Steven Rogers Senior Vice President, General Counsel, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Charles J. Alaimo Senior Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
Raymond Bartone Senior Vice President - Nutritionals
Age: 53
Bio & Compensation  - Reuters
Frank V. DeBenedittis Senior Vice President - Corporate Business Development
Age: 61
Bio & Compensation  - Reuters
Terry Kippley Senior Vice President - Agricultural Protection Products
Age: 51
Bio & Compensation  - Reuters